The Many Faces of Recreational Drug Use - Episode 1
Drug addiction is a devastating condition that affects the quality of the user and their families. In this podcast series, we explore the behaviors of individuals who abuse opioids and stimulants, and learn about their patterns of use and motivations to compel them to continue using these drugs through a series of candid interviews with opioid and stimulant recreational drug users.
Contract Pharma: Altasciences Appoints Dr. Bruce Frank as VP, CDMO Operations
Alzamend Neuro Announces It Has Contracted with Altasciences to Conduct a Phase I Relative Bioavailability Study for AL001 for Dementia Related to Alzheimer's Disease in September 2021
Proactive: Emyria Signs Pure CBD Agreement with U.S.-based Altasciences to Help Fast Track Registration
Proactive: Emyria to Accelerate FDA and TGA CBD Registration Programs with Altasciences Deal
We Deliver Your Projects On-Time.
On-Time Delivery
Over the last 12 months, our project management team has played a key role in achieving a 99% on-time delivery success rate on your primary KPIs.
Altasciences’ high-quality project management is key to the success of your drug development programs, and is an integral part of our service offering. Our project management team has extensive expertise in managing studies for a wide range of therapeutic areas in small and large molecules, and will oversee every aspect of your study.
Partner with us to ensure seamless and timely communication for the successful completion of your project.
You may also be interested in the following:
Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Which Dosage Form Gets Your Drug to Market Faster?
Liquid-Filled Capsules ― Getting Your Drug to Market, Fast
Altasciences has developed and manufactured practically every dosage form on the market, and our experts agree that liquid-filled, two-piece, hard-shell capsules (LFCs) offer several advantages over other solid dosage forms, such as ease of scalability and manufacturing, faster absorption, simpler packaging, and excellent product stability.
With LFCs, scientists can effectively formulate poorly soluble drugs, while reducing development time and costs.
Watch our Executive Vice President of Operations, Ben Reed, explain in more detail.
Are liquid-filled capsules suitable for your API? Speak with an expert to find out.
You may also be interested in the following:
- Webpage: Pharmaceutical Contract Manufacturing Services
- Webpage: Analytical Laboratory Services
- Webinar: Manufacturing Solutions Using Liquid-Filled Capsules
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.
Up Close and Personal with Dr. David Nguyen, MD, MBA
Dr.
Ocular Toxicology ― Keeping an EYE on Success
We Share Your Vision
Altasciences has performed safety assessments of test articles administered via numerous ocular routes for over 50 years, including for nanoparticles and ocular implants.
Common routes of administration include, but are not limited to:
- Intravitreal injection
- Subretinal injection
- Anterior chamber injection
- Subconjunctival injection
- Topical instillation
We have supported a significant number of successful global regulatory submissions in terms of study design, conduct, and data integrity. Study durations have ranged from single-dose acute studies to six- and nine-month studies.
You may also be interested in the following:
- Webpages:
Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept, and beyond.